Stephen DAMMENT,Richard FRANKLIN,Jorge D. ERUSALIMSKY
申请号:
US15538326
公开号:
US20170360793A1
申请日:
2015.12.22
申请国别(地区):
US
年份:
2017
代理人:
摘要:
The present invention relates to the use of the anti-megakaryocytic agent anagrelide, or a therapeutically active metabolite thereof, in the prevention or treatment of metastatic disease in cancer patients displaying paraneoplastic thrombocytosis.